“…The pro-longevity effects of FOXO overexpression in mammals await experimentation, but genetic variances in the FOXO3A loci are enriched in human centenarians (Barzilai, Huffman, Muzumdar, & Bartke, 2012;Slagboom et al, 2011). Given that FOXO is considered the downstream pro-longevity effector of IIS down-regulation, research is focusing on identifying either a transcriptional signature for healthy life span or the genes that modulate the aging process (Alic, Andrews, et al, 2011;Bai, Kang, Hernandez, & Tatar, 2013;McElwee et al, 2007;Murphy et al, 2003;Schuster et al, 2010;Tullet, 2014). It has been documented that the DAF-16 transcriptional response includes the activation of cellular defense mechanisms, including genes with antioxidant properties like superoxide dismutases and catalases (five and three, respectively in C. elegans), genes encoding for peptides with antipathogenicity effects, detoxification, and heat-shock proteins (Murphy, 2006;Shore & Ruvkun, 2013).…”